The evidence from observational studies of other GLP-1 receptor agonists has been mixed, with some studies showing no increased risk while others suggest a possible small increase in thyroid cancer diagnoses, though causality remains uncertain
The clinical researcher in me is excited by the numbers
January 2026 is aligning with commonly observed early-year interest in oral GLP-1 peptide options, as consumers compare different administration formats during seasonal "new year, new you" wellness behavior
Qualifying for Weight Loss Medications Klinic prescribes weight loss medications to adults with a BMI of 30 or higher, or a BMI of 27 with related conditions
Patient portal messaging is available for current patients
The Nature Medicine study analysed data from the US Department of Veterans Affairs to explore the associations between GLP-1RA and 175 health outcomes in 215,970 people with diabetes